These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29880630)

  • 1. Development and Characterization of a Human Hepatocyte Low Intrinsic Clearance Assay for Use in Drug Discovery.
    Lancett P; Williamson B; Barton P; Riley RJ
    Drug Metab Dispos; 2018 Aug; 46(8):1169-1178. PubMed ID: 29880630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upcyte Human Hepatocytes: a Potent In Vitro Tool for the Prediction of Hepatic Clearance of Metabolically Stable Compounds.
    Schaefer M; Schänzle G; Bischoff D; Süssmuth RD
    Drug Metab Dispos; 2016 Mar; 44(3):435-44. PubMed ID: 26712819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac.
    Chan TS; Yu H; Moore A; Khetani SR; Tweedie D
    Drug Metab Dispos; 2013 Dec; 41(12):2024-32. PubMed ID: 23959596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
    Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
    Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes.
    Lin C; Shi J; Moore A; Khetani SR
    Drug Metab Dispos; 2016 Jan; 44(1):127-36. PubMed ID: 26452722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds: Comparison of a Primary Hepatocyte/Stromal Cell Co-culture with Plated Primary Hepatocytes and HepaRG.
    Bonn B; Svanberg P; Janefeldt A; Hultman Ia; Grime K
    Drug Metab Dispos; 2016 Apr; 44(4):527-33. PubMed ID: 26851239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes.
    Docci L; Klammers F; Ekiciler A; Molitor B; Umehara K; Walter I; Krähenbühl S; Parrott N; Fowler S
    AAPS J; 2020 Oct; 22(6):131. PubMed ID: 33051808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Prediction of Human Hepatic Clearance for P450 and Non-P450 Substrates from In Vivo Monkey Pharmacokinetics Study and In Vitro Metabolic Stability Tests Using Hepatocytes.
    Nishimuta H; Watanabe T; Bando K
    AAPS J; 2019 Jan; 21(2):20. PubMed ID: 30673906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the Unstirred Water Layer and Hepatocyte Membrane Integrity In Vitro for Quantification of Intrinsic Metabolic Clearance.
    Wood FL; Houston JB; Hallifax D
    Drug Metab Dispos; 2018 Mar; 46(3):268-278. PubMed ID: 29233818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel relay method for determining low-clearance values.
    Di L; Trapa P; Obach RS; Atkinson K; Bi YA; Wolford AC; Tan B; McDonald TS; Lai Y; Tremaine LM
    Drug Metab Dispos; 2012 Sep; 40(9):1860-5. PubMed ID: 22645091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity.
    Qiao S; Feng S; Wu Z; He T; Ma C; Peng Z; Tian E; Pan G
    Drug Metab Dispos; 2021 Apr; 49(4):305-313. PubMed ID: 33526515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Human Hepatic Clearance for Cytochrome P450 Substrates via a New Culture Method Using the Collagen Vitrigel Membrane Chamber and Fresh Hepatocytes Isolated from Liver Humanized Mice.
    Watari R; Kakiki M; Yamasaki C; Ishida Y; Tateno C; Kuroda Y; Ishida S; Kusano K
    Biol Pharm Bull; 2019; 42(3):348-353. PubMed ID: 30828066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
    Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies.
    Kanebratt KP; Janefeldt A; Vilén L; Vildhede A; Samuelsson K; Milton L; Björkbom A; Persson M; Leandersson C; Andersson TB; Hilgendorf C
    J Pharm Sci; 2021 Jan; 110(1):422-431. PubMed ID: 33122050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design.
    Di L; Keefer C; Scott DO; Strelevitz TJ; Chang G; Bi YA; Lai Y; Duckworth J; Fenner K; Troutman MD; Obach RS
    Eur J Med Chem; 2012 Nov; 57():441-8. PubMed ID: 22840492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.
    Schaefer O; Ohtsuki S; Kawakami H; Inoue T; Liehner S; Saito A; Sakamoto A; Ishiguro N; Matsumaru T; Terasaki T; Ebner T
    Drug Metab Dispos; 2012 Jan; 40(1):93-103. PubMed ID: 21979928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery.
    Sahi J; Grepper S; Smith C
    Curr Drug Discov Technol; 2010 Sep; 7(3):188-98. PubMed ID: 20843293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the intestinal first-pass metabolism of CYP3A and UGT substrates in humans from in vitro data.
    Nishimuta H; Sato K; Yabuki M; Komuro S
    Drug Metab Pharmacokinet; 2011; 26(6):592-601. PubMed ID: 21878741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
    Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
    Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.